Authorize.Net vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Visa-owned (V) payment gateway processing $149B annually for 445K+ merchants; 20+ year legacy platform reimagined in April 2025 with AI fraud protection competing with Stripe for online payment processing.
About
Authorize.Net is a leading US payment gateway providing credit card, debit card, e-check, and digital wallet processing infrastructure for online, in-person, and phone transactions for 445,000+ merchants globally — processing over 1 billion transactions and $149 billion in payment volume annually as of 2025. Founded in 1996 in Salt Lake City, Authorize.Net was acquired by CyberSource in 2007, and then by Visa (NYSE: V) through its $2 billion acquisition of CyberSource in 2010, becoming part of Visa's merchant-facing commerce solutions portfolio.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.